What options might be available when treatment needs to pause or change due to low WBC levels during kappa light chain myeloma treatment?
Having a treatment pause due to low white blood cell counts is actually quite common during myeloma therapy — your care team is protecting you by holding off. It's frustrating, but it's Show Full Answer
What options might be available when treatment needs to pause or change due to low WBC levels during kappa light chain myeloma treatment?
Having a treatment pause due to low white blood cell counts is actually quite common during myeloma therapy — your care team is protecting you by holding off. It's frustrating, but it's the right call.
Here are some things worth discussing with your oncologist: While WBC counts recover, your team may consider:
- Growth factor injections (like Neupogen/filgrastim) to help boost white blood cell production
- Dose adjustments to your current DVCD regimen
- Delaying the next cycle until counts are safe
Regarding what's next in your treatment journey:
- With 20-30% plasma cell involvement shown on bone marrow biopsy, your team will want to reassess response after your current induction regimen
- A stem cell transplant evaluation may be discussed if you're eligible, as it tends to improve outcomes
- Your kappa light chains will be closely monitored, as they can affect kidney function — especially relevant given your nephrotic syndrome
Questions worth raising with your specialist:
- Is a treatment regimen adjustment needed?
- Should a specialist at an academic or major cancer center be involved in your care?
- Are there clinical trials available for your specific profile?
Being treated at or consulting with an academic medical center or major cancer network can make a meaningful difference in outcomes.
July 28
Join
Your Privacy Choices
